Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study

1. Van Cutsem, E.
2. Martinelli, E.
3. Cascinu, S.
4. Sobrero, A.
5. Banzi, M.
6. Seitz, J.-F.
7. Barone, C.
8. Ychou, M.
9. Peeters, M.
10. Brenner, B.
11. Hofheinz, R.D.
12. Maiello, E.
13. André, T.
14. Spallanzani, A.
15. Garcia-Carbonero, R.
16. Arriaga, Y.E.
17. Verma, U.
18. Grothey, A.
19. Kappeler, C.
20. Miriyala, A.
21. Kalmus, J.
22. Falcone, A.
23. Zaniboni, A.